ViewRay Inc. gets FDA approval to market its next-generation MRIdian Linac system

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

ViewRay Inc. (Nasdaq: VRAY) of Oakwood Village said it received clearance from the U.S. Food and Drug Administration to market the MRIdian Linac system, its next-generation MRI-guided radiation therapy system. FDA clearance (go here for the clearance document) of the MRIdian Linac “is a transformative milestone for ViewRay,” said Chris A. Raanes, president and CEO of ViewRay, in a statement.

Click here to read the complete article.

Originally published February 27, 2017.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: